Acquisition of Pharma Bio-Research by HgCapital (UK)

Pharma Bio-Research Group B.V., the leading European provider of Phase I/II A clinical trials was sold in an LBO to HgCapital, one of the leading private equity providers.
PhiDelphi acted on behalf of the management.

Utrechtseweg 29 | Hilversum | +31 35 672 76 00